文献速递其他结缔组织病血管炎

心脏磁共振原生心肌T1与右心室大小预测系统性硬化症相关肺动脉高压的结局

Native myocardial T1 and right ventricular size by CMR predict outcome in systemic sclerosis-associated pulmonary hypertension.
PubMed 文献 · Rheumatology (Oxford) · 2024-01-01

该回顾性单中心观察研究纳入148例经右心导管确诊的系统性硬化症相关肺动脉高压患者,分析其临床指征下心脏磁共振(含原生心肌T1、T2映射)的预后价值。中位随访3.5年期间66例(45%)死亡,校正年龄后右心室收缩末期容积指数(RVESVi,P=0.0023)与原生T1(P=0.0024)均为全因死亡的独立预测因素。RVESVi≤38 mL/m2且原生T1≤1119 ms的患者结局显著优于其他组合(P<0.001)。

要点

  • 在SSc-PH患者中,RVESVi与原生心肌T1经年龄校正后均为全因死亡的独立预测因素。
  • RVESVi与原生T1的最佳预后阈值分别为≤38 mL/m2和≤1119 ms(P<0.001)。
  • RVESVi≤38 mL/m2且原生T1≤1119 ms的患者结局显著优于其他所有组合(P<0.001)。

核心结论

  • 研究识别了SSc-PH患者具有预后相关性的心脏磁共振指标及其阈值。
  • 在评估右心室功能的同时评估心肌组织特征可为SSc-PH提供附加价值,并可能代表额外的治疗靶点。

研究设计与样本

  • 回顾性、单中心、观察性研究,纳入148例经右心导管确诊的系统性硬化症相关肺动脉高压患者。
  • 患者于2016年至2023年接受临床指征下的心脏磁共振检查,包括原生心肌T1与T2映射。

主要发现

  • 随访期间66例(45%)患者死亡,中位随访3.5年(范围0.1-7.3年)。
  • 死亡患者年龄更大(65 vs 60岁,P=0.035),右心室更扩张(P<0.001)、更肥厚(P=0.013)且功能受损(P<0.001),右心房更扩张(P=0.043),原生心肌T1更高(P<0.001)。
  • 校正年龄后,RVESVi(P=0.0023)与原生T1(P=0.0024)为全因死亡的独立预测因素;校正年龄与PH亚型后两者仍为独立预测因素(RVESVi P<0.001,T1 P=0.0056)。
  • RVESVi与原生T1的最佳预后阈值分别为≤38 mL/m2和≤1119 ms(P<0.001)。
  • RVESVi≤38 mL/m2且原生T1≤1119 ms的患者结局显著优于其他所有组合(P<0.001);RVESVi>38 mL/m2且原生T1≤1119 ms的患者生存显著优于RVESVi>38 mL/m2且原生T1>1119 ms的患者(P=0.017)。

关键数值与推荐

  • RVESVi最佳预后阈值为≤38 mL/m2(P<0.001)。
  • 原生心肌T1最佳预后阈值为≤1119 ms(P<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Measures of right heart size and function are prognostic in systemic sclerosis-associated pulmonary hypertension (SSc-PH), but the importance of myocardial tissue characterisation remains unclear. We aimed to investigate the predictive potential and interaction of cardiovascular magnetic resonance (CMR) myocardial tissue characterisation and right heart size and function in SSc-PH. METHODS: A retrospective, single-centre, observational study of 148 SSc-PH patients confirmed by right heart catheterization who underwent clinically indicated CMR including native myocardial T1 and T2 mapping from 2016 to 2023 was performed. RESULTS: Sixty-six (45%) patients died during follow-up (median 3.5 years, range 0.1-7.3). Patients who died were older (65 vs 60 years, P = 0.035) with more dilated (P < 0.001), hypertrophied (P = 0.013) and impaired (P < 0.001) right ventricles, more dilated right atria (P = 0.043) and higher native myocardial T1 (P < 0.001).After adjustment for age, indexed right ventricular end-systolic volume (RVESVi, P = 0.0023) and native T1 (P = 0.0024) were independent predictors of all-cause mortality. Both RVESVi and native T1 remained independently predictive after adjusting for age and PH subtype (RVESVi P < 0.001, T1 P = 0.0056). Optimal prognostic thresholds for RVESVi and native T1 were ≤38 mL/m2 and ≤1119 ms, respectively (P < 0.001). Patients with RVESVi ≤ 38 mL/m2 and native T1 ≤ 1119 ms had significantly better outcomes than all other combinations (P < 0.001). Furthermore, patients with RVESVi > 38mL/m2 and native T1 ≤ 1119 ms had significantly better survival than patients with RVESVi > 38mL/m2 and native T1 > 1119ms (P = 0.017). CONCLUSION: We identified prognostically relevant CMR metrics and thresholds for patients with SSc-PH. Assessing myocardial tissue characterisation alongside right ventricular function confers added value in SSc-PH and may represent an additional treatment target.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Knight DS, Virsinskaite R, Karia N, et al. Native myocardial T1 and right ventricular size by CMR predict outcome in systemic sclerosis-associated pulmonary hypertension. Rheumatology (Oxford). 2024. PMID: 38759116. doi:10.1093/rheumatology/keae141

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。